Variability of Tinnitus Characterization Tools and Investigation of Audiovisual Integration in Tinnitus Perception

September 13, 2017 updated by: University of Minnesota

Characterizing the nature and severity of tinnitus in individuals presents a particular challenge. The nature of the sound (loudness and pitch) is not necessarily indicative of the effect on quality of life. Different methods are used to measure each parameter. Loudness is measured using a technique called "minimum masking," in which the subject is presented with a broadband white noise and asked to adjust the loudness level until they can no longer hear their tinnitus. Severity of tinnitus is commonly characterized using two questionnaires: the Tinnitus Handicap Inventory (THI) and the Tinnitus Functional Index (TFI). These questionnaires assess the perceived severity of the tinnitus and the effect on everyday activities and quality of life. A visual analog scale (a scale from 0-10) is used as a general subjective measurement of tinnitus severity. In the first part of this study, we will measure each of these parameters over a series of sessions to establish a baseline variability for each individual.

The second part will look at the influence of context-specific visual information on auditory perception. This involves watching silent videos of a person speaking, with and without an additional tone designed to match the subject's tinnitus. The effect of this audiovisual feedback on the subject's perception of tinnitus will be assessed using a subjective rating scale and the minimum masking task.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

This study is not specifically seeking to treat tinnitus, but is designed to investigate various parameters that can alter the tinnitus percept. Findings from this study will help identify parameters that can be more effective at decreasing or fully suppressing the tinnitus percept that will be systematically explored in a follow-up study.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota, Nils Hasselmo Hall, 6-105

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have subjective, non-pulsatile and bothersome tinnitus
  • Ability to give informed consent and understand study objectives and procedures in English
  • Willing and able to understand and comply with all study-related procedures
  • Will not start any new tinnitus treatment during the study

Exclusion Criteria:

  • Substantial hearing loss or hyperacusis that may interfere with the study
  • Medical history of other ear or brain disorders
  • Pregnant or currently breast-feeding (we need to give all female subjects a pregnancy test because pregnant females and unborn children require extra protection for their safety)
  • Any handicap that prevents the subject from reliably performing the tests, such as blindness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Characterization, Audiovisual

Characterization: Tinnitus characterization tools (Minimal Masking Level, Tinnitus Functional Index, Tinnitus Handicap Inventory, and Subjective rating scale) are assessed in an individual over time to determine baseline variability.

Audiovisual: The individual will watch a series of silent videos of a person speaking, both with and without a tone matched to their tinnitus as well as videos of a still face with and without the matched tone.

Band-limited white noise stimulus or frequency-matched tone presented at a comfortable loudness level via headphones or earphones.
Silent video recording of a person speaking or a still face with an expanding circle over the mouth presented on a computer or tablet screen.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Minimal Masking Level
Time Frame: Change in baseline level at an expected average of 1 minute and 1.5 hours after testing paradigm.
A narrowband noise (from 2-12 kHz) is presented to the tinnitus ear and the minimum sound level (in decibel sound pressure level, decibel SPL) is determined that completely masks the tinnitus percept.
Change in baseline level at an expected average of 1 minute and 1.5 hours after testing paradigm.
Change in Tinnitus Rating (0-10, 10 being worst)
Time Frame: Change in baseline rating at an expected average of 4 minutes and 1.5 hours after testing paradigm
the subject rates the disturbance or bothering nature of the tinnitus.
Change in baseline rating at an expected average of 4 minutes and 1.5 hours after testing paradigm

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Tinnitus Functional Index Questionnaire Score
Time Frame: Change from baseline score at an expected average of 5 minutes and 1.5 hours after testing paradigm
A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score.
Change from baseline score at an expected average of 5 minutes and 1.5 hours after testing paradigm
Change in Tinnitus Handicap Inventory Questionnaire Score
Time Frame: Change from baseline score at an expected average of 5 minutes and 1.5 hours after testing paradigm
A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score.
Change from baseline score at an expected average of 5 minutes and 1.5 hours after testing paradigm
Change in Tinnitus Subjective Description
Time Frame: Change in baseline description at an expected average of 5 minutes and 1.5 hours after testing paradigm
The subject describes the quality, characteristics, and bothering nature of the tinnitus.
Change in baseline description at an expected average of 5 minutes and 1.5 hours after testing paradigm

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hubert Lim, PhD, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2017

Primary Completion (Anticipated)

January 1, 2018

Study Completion (Anticipated)

January 1, 2018

Study Registration Dates

First Submitted

March 17, 2016

First Submitted That Met QC Criteria

March 17, 2016

First Posted (Estimate)

March 23, 2016

Study Record Updates

Last Update Posted (Actual)

September 14, 2017

Last Update Submitted That Met QC Criteria

September 13, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tinnitus

Clinical Trials on Tone

Subscribe